{{Rsnum
|rsid=7300972
|Gene=SELPLG
|Chromosome=12
|position=108623488
|Orientation=plus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.08402
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SELPLG
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 8.0 | 92.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 10.3 | 43.2 | 46.6
| ASW | 5.4 | 46.4 | 48.2
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 10.9 | 89.1
| LWK | 7.3 | 40.0 | 52.7
| MEX | 0.0 | 5.2 | 94.8
| MKK | 3.2 | 24.4 | 72.4
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}[[rs7300972]], a SNP in the [[SELPLG]] gene also known as M264V, is associated with risk for developing [[Non-Hodgkin Lymphoma]] based on a study of 458 patients. The odds ratio is 3.20 (CI: 1.48-6.91, p<0.01). {{PMID|17827388|OA=1
}}

{{GET Evidence
|gene=SELPLG
|aa_change=SerMet263PheVal
|aa_change_short=SM263FV
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7300972
|overall_frequency_n=11
|overall_frequency_d=128
|overall_frequency=0.0859375
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|nblosum100=5
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}